Martin D. Madaus - 03 Jan 2022 Form 4 Insider Report for Quanterix Corp (QTRX)

Role
Director
Signature
/s/ Brian Keane, Attorney-in-Fact
Issuer symbol
QTRX
Transactions as of
03 Jan 2022
Transactions value $
$18,109
Form type
4
Filing time
05 Jan 2022, 15:06:41 UTC
Previous filing
05 Oct 2021
Next filing
06 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTRX Common Stock Award $0 +2.67K +17.38% $0.00 18K 03 Jan 2022 Direct F1, F2
transaction QTRX Common Stock Award $18.1K +427 +2.37% $42.41 18.4K 03 Jan 2022 Direct F2, F3, F4
holding QTRX Common Stock 165K 03 Jan 2022 See Footnote F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTRX Stock Option (Right to Buy) Award $0 +4K $0.00 4K 03 Jan 2022 Common Stock 4K $42.41 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest as to 100% of the shares on December 31, 2022 granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
F2 Includes 2,668 restricted stock units.
F3 Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2021.
F4 Closing price of the Company's common stock on the Nasdaq Global Market on January 3, 2022.
F5 Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control.
F6 Represents non-qualified stock option to purchase 4,002 shares of common stock granted pursuant to the Quanterix Corporation 2018 Non-Employee Director Compensation Policy.